OKUR earnings: next report 2026-08-11, real EPS beat/miss history, analyst consensus Buy, P/E -1.00. Updated 2026-07-23.
OnKure Therapeutics (OKUR) Research Hub
OnKure Therapeutics (OKUR) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 3.1 USD (-8.28%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -1.00, market cap 0.06B. This hub links to the full technical, earnings and options research available for OKUR.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 3.1 USD (-8.28%) |
| 52-week range | 2.98 USD – 4.76 USD |
| Trend regime | Range |
| 14-day RSI | 15.3 (Oversold) |
| Trailing P/E | -1.00 |
| Market cap | 0.06B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-11 |
Available research for OKUR
Covered Call on OKUR: how it works, illustrative setup around the real 3.1 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on OKUR: how it works, illustrative setup around the real 3.1 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on OKUR: how it works, illustrative setup around the real 3.1 USD price, max profit/loss, breakeven and when to use it. Educational.
OKUR technical analysis: range, last 3.1 USD, RSI 15.3, 52w range 2.98 USD–4.76 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is OKUR in?
OnKure Therapeutics (OKUR) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is OKUR in an uptrend or downtrend?
As of 2026-09-11, OKUR is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is OKUR's trailing P/E ratio?
OKUR's trailing P/E is -1.00, with a market cap of 0.06B. See the earnings research page for full valuation detail.
When does OKUR next report earnings?
OKUR is next scheduled to report earnings on 2026-08-11, with a consensus EPS estimate of -0.58 USD.